-
1
-
-
77953842683
-
Current development and future prospects in chemotherapy of tuberculosis
-
Nuermberger EL, Spigelman MK, Yew WW: Current development and future prospects in chemotherapy of tuberculosis. Respirology 2010;15:764-778.
-
(2010)
Respirology
, vol.15
, pp. 764-778
-
-
Nuermberger, E.L.1
Spigelman, M.K.2
Yew, W.W.3
-
2
-
-
38049038389
-
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model
-
Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL: Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model. PLoS Med 2007;4:e344.
-
(2007)
PLoS Med
, vol.4
, pp. e344
-
-
Rosenthal, I.M.1
Zhang, M.2
Williams, K.N.3
Peloquin, C.A.4
Tyagi, S.5
Vernon, A.A.6
Bishai, W.R.7
Chaisson, R.E.8
Grosset, J.H.9
Nuermberger, E.L.10
-
3
-
-
53549104456
-
Using animal models to develop new treatments for tuberculosis
-
Nuermberger E: Using animal models to develop new treatments for tuberculosis. Semin Respir Crit Care Med 2008;29:542-551.
-
(2008)
Semin Respir Crit Care Med
, vol.29
, pp. 542-551
-
-
Nuermberger, E.1
-
4
-
-
9644255803
-
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis
-
Nikonenko BV, Samala R, Einck L, Nacy CA:Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004;48:4550-4555.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 4550-4555
-
-
Nikonenko, B.V.1
Samala, R.2
Einck, L.3
Nacy, C.A.4
-
5
-
-
16544389763
-
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis
-
Shoen CM, De Stefano MS, Sklaney MR, Monica BJ, Slee AM, Cynamon MH: Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis. J Antimicrob Chemother 2004;53:641-645.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 641-645
-
-
Shoen, C.M.1
De Stefano, M.S.2
Sklaney, M.R.3
Monica, B.J.4
Slee, A.M.5
Cynamon, M.H.6
-
6
-
-
77951213047
-
Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis
-
Rullas J, Garcia JI, Beltran M, Cardona PJ, Caceres N, Garcia-Bustos JF, Angulo-Barturen I: Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis. Antimicrob Agents Chemother 2010;54:2262-2264.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2262-2264
-
-
Rullas, J.1
Garcia, J.I.2
Beltran, M.3
Cardona, P.J.4
Caceres, N.5
Garcia-Bustos, J.F.6
Angulo-Barturen, I.7
-
7
-
-
0037310195
-
Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon genedisrupted mice
-
Lenaerts AJ, Gruppo V, Brooks JV, Orme IM:Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon genedisrupted mice. Antimicrob Agents Chemother 2003;47:783-785.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 783-785
-
-
Lenaerts, A.J.1
Gruppo, V.2
Brooks, J.V.3
Orme, I.M.4
-
8
-
-
0034702247
-
A smallmolecule nitroimidazopyran drug candidate for the treatment of tuberculosis
-
Stover CK, Warrener P, Van Devanter DR, Sherman DR, Arain TM, Langhorne MH, Anderson SW, Towell JA, Yuan Y, McMurray DN, Kreiswirth BN, Barry CE, Baker WR: A smallmolecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000;405:962-966.
-
(2000)
Nature
, vol.405
, pp. 962-966
-
-
Stover, C.K.1
Warrener, P.2
Van Devanter, D.R.3
Sherman, D.R.4
Arain, T.M.5
Langhorne, M.H.6
Anderson, S.W.7
Towell, J.A.8
Yuan, Y.9
McMurray, D.N.10
Kreiswirth, B.N.11
Barry, C.E.12
Baker, W.R.13
-
9
-
-
77956534319
-
Optimisation of bioluminescent reporters for use with mycobacteria
-
Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, Wiles S: Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One 2010;5:e10777.
-
(2010)
PLoS One
, vol.5
, pp. e10777
-
-
Andreu, N.1
Zelmer, A.2
Fletcher, T.3
Elkington, P.T.4
Ward, T.H.5
Ripoll, J.6
Parish, T.7
Bancroft, G.J.8
Schaible, U.9
Robertson, B.D.10
Wiles, S.11
-
10
-
-
70350322939
-
Noninvasive pulmonary [18F]-2-fluoro-deoxy-dglucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment
-
Davis SL, Nuermberger EL, Um PK, Vidal C, Jedynak B, Pomper MG, Bishai WR, Jain SK: Noninvasive pulmonary [18F]-2-fluoro-deoxy-dglucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother 2009;53:4879-4884.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4879-4884
-
-
Davis, S.L.1
Nuermberger, E.L.2
Um, P.K.3
Vidal, C.4
Jedynak, B.5
Pomper, M.G.6
Bishai, W.R.7
Jain, S.K.8
-
11
-
-
67650895342
-
Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals
-
Davis SL, Be NA, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR, Jain SK: Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals. PLoS One 2009;4:e6297.
-
(2009)
PLoS One
, vol.4
, pp. e6297
-
-
Davis, S.L.1
Be, N.A.2
Lamichhane, G.3
Nimmagadda, S.4
Pomper, M.G.5
Bishai, W.R.6
Jain, S.K.7
-
12
-
-
78049264832
-
Bactericidal potencies of new regimens are not predictive for their sterilizing potencies in a murine model of tuberculosis
-
Andries K, Gevers T, Lounis N: Bactericidal potencies of new regimens are not predictive for their sterilizing potencies in a murine model of tuberculosis. Antimicrob Agent Chemother 2010;54:4540-4544.
-
(2010)
Antimicrob Agent Chemother
, vol.54
, pp. 4540-4544
-
-
Andries, K.1
Gevers, T.2
Lounis, N.3
-
13
-
-
34248345917
-
In vivo adaptation of the Wayne model of latent tuberculosis
-
Woolhiser L, Tamayo MH, Wang B, Gruppo V, Belisle JT, Lenaerts AJ, Basaraba RJ, Orme IM: In vivo adaptation of the Wayne model of latent tuberculosis. Infect Immun 2007;75:2621-2625.
-
(2007)
Infect Immun
, vol.75
, pp. 2621-2625
-
-
Woolhiser, L.1
Tamayo, M.H.2
Wang, B.3
Gruppo, V.4
Belisle, J.T.5
Lenaerts, A.J.6
Basaraba, R.J.7
Orme, I.M.8
-
14
-
-
77957375205
-
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis
-
Sala C, Dhar N, Hartkoorn RC, Zhang M, Ha YH, Schneider P, Cole ST: Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 2010;54:4150-4158.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4150-4158
-
-
Sala, C.1
Dhar, N.2
Hartkoorn, R.C.3
Zhang, M.4
Ha, Y.H.5
Schneider, P.6
Cole, S.T.7
-
15
-
-
0024434790
-
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide
-
Lecoeur HF, Truffot-Pernot C, Grosset JH: Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis 1989;140:1189-1193.
-
(1989)
Am Rev Respir Dis
, vol.140
, pp. 1189-1193
-
-
Lecoeur, H.F.1
Truffot-Pernot, C.2
Grosset, J.H.3
-
16
-
-
67749108046
-
Experimental models of tuberculosis: can we trust the mouse?
-
Mitchison DA, Chang KC: Experimental models of tuberculosis: can we trust the mouse? Am J Respir Crit Care Med 2009;180:201-202.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 201-202
-
-
Mitchison, D.A.1
Chang, K.C.2
-
17
-
-
30344437254
-
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model
-
Nuermberger E, Tyagi S, Williams KN, Rosenthal I, Bishai WR, Grosset JH: Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model. Am J Respir Crit Care Med 2005;172:1452-1456.
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 1452-1456
-
-
Nuermberger, E.1
Tyagi, S.2
Williams, K.N.3
Rosenthal, I.4
Bishai, W.R.5
Grosset, J.H.6
-
18
-
-
72749096722
-
Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection
-
Zhang T, Zhang M, Rosenthal IM, Grosset JH, Nuermberger EL: Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection. Am J Respir Crit Care Med 2009;180:1151-1157.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 1151-1157
-
-
Zhang, T.1
Zhang, M.2
Rosenthal, I.M.3
Grosset, J.H.4
Nuermberger, E.L.5
-
19
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
-
Craig WA: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1-10
-
-
Craig, W.A.1
-
20
-
-
3343001838
-
Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis
-
Jayaram R, Shandil RK, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Kantharaj E, Balasubramanian V: Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother 2004;48:2951-2957.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 2951-2957
-
-
Jayaram, R.1
Shandil, R.K.2
Gaonkar, S.3
Kaur, P.4
Suresh, B.L.5
Mahesh, B.N.6
Jayashree, R.7
Nandi, V.8
Bharath, S.9
Kantharaj, E.10
Balasubramanian, V.11
-
21
-
-
0030805449
-
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis
-
Donald PR, Sirgel FA, Botha FJ, Seifart HI, Parkin DP, Vandenplas ML, Van de Wal BW, Maritz JS, Mitchison DA: The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997;156:895-900.
-
(1997)
Am J Respir Crit Care Med
, vol.156
, pp. 895-900
-
-
Donald, P.R.1
Sirgel, F.A.2
Botha, F.J.3
Seifart, H.I.4
Parkin, D.P.5
Vandenplas, M.L.6
Van de Wal, B.W.7
Maritz, J.S.8
Mitchison, D.A.9
-
22
-
-
0030732565
-
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide
-
Peloquin CA, Jaresko GS, Yong CL, Keung AC, Bulpitt AE, Jelliffe RW: Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide. Antimicrob Agents Chemother 1997;41:2670-2679.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 2670-2679
-
-
Peloquin, C.A.1
Jaresko, G.S.2
Yong, C.L.3
Keung, A.C.4
Bulpitt, A.E.5
Jelliffe, R.W.6
-
23
-
-
34447251840
-
Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations
-
Gumbo T, Louie A, Liu W, Brown D, Ambrose PG, Bhavnani SM, Drusano GL: Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations. Antimicrob Agents Chemother 2007;51:2329-2336.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 2329-2336
-
-
Gumbo, T.1
Louie, A.2
Liu, W.3
Brown, D.4
Ambrose, P.G.5
Bhavnani, S.M.6
Drusano, G.L.7
-
24
-
-
0037662753
-
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis
-
Jayaram R, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharat S, Shandil RK, Kantharaj E, Balasubramanian V: Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother 2003;47:2118-2124.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 2118-2124
-
-
Jayaram, R.1
Gaonkar, S.2
Kaur, P.3
Suresh, B.L.4
Mahesh, B.N.5
Jayashree, R.6
Nandi, V.7
Bharat, S.8
Shandil, R.K.9
Kantharaj, E.10
Balasubramanian, V.11
-
25
-
-
78650642282
-
PA-824 exhibits time-dependent activity in a murine model of tuberculosis
-
Ahmad Z, Peloquin CA, Singh RP, Derendorf H, Tyagi S, Ginsberg A, Grosset JH, Nuermberger EL: PA-824 exhibits time-dependent activity in a murine model of tuberculosis. Antimicrob Agents Chemother 2011;55:239-245.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 239-245
-
-
Ahmad, Z.1
Peloquin, C.A.2
Singh, R.P.3
Derendorf, H.4
Tyagi, S.5
Ginsberg, A.6
Grosset, J.H.7
Nuermberger, E.L.8
-
26
-
-
70349330225
-
Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig
-
Ahmad Z, Klinkenberg LG, Pinn ML, Fraig MM, Peloquin CA, Bishai WR, Nuermberger EL, Grosset JH, Karakousis PC: Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J Infect Dis 2009;200:1136-1143.
-
(2009)
J Infect Dis
, vol.200
, pp. 1136-1143
-
-
Ahmad, Z.1
Klinkenberg, L.G.2
Pinn, M.L.3
Fraig, M.M.4
Peloquin, C.A.5
Bishai, W.R.6
Nuermberger, E.L.7
Grosset, J.H.8
Karakousis, P.C.9
-
27
-
-
77952572253
-
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig
-
Ahmad Z, Nuermberger EL, Tasneen R, Pinn ML, Williams KN, Peloquin CA, Grosset JH, Karakousis PC: Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. J Antimicrob Chemother 2010;65:729-734.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 729-734
-
-
Ahmad, Z.1
Nuermberger, E.L.2
Tasneen, R.3
Pinn, M.L.4
Williams, K.N.5
Peloquin, C.A.6
Grosset, J.H.7
Karakousis, P.C.8
-
28
-
-
77957229965
-
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters
-
Ahmad Z, Pinn ML, Nuermberger EL, Peloquin CA, Grosset JH, Karakousis PC: The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters. J Antimicrob Chemother 2010;65:2172-2175.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 2172-2175
-
-
Ahmad, Z.1
Pinn, M.L.2
Nuermberger, E.L.3
Peloquin, C.A.4
Grosset, J.H.5
Karakousis, P.C.6
-
29
-
-
47649096186
-
Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency
-
Klinkenberg LG, Sutherland LA, Bishai WR, Karakousis PC: Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J Infect Dis 2008;198:275-283.
-
(2008)
J Infect Dis
, vol.198
, pp. 275-283
-
-
Klinkenberg, L.G.1
Sutherland, L.A.2
Bishai, W.R.3
Karakousis, P.C.4
-
30
-
-
46249108568
-
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
-
Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E, Manjunatha U, Gonzales J, Lee EG, Park SK, Raleigh JA, Cho SN, McMurray DN, Flynn JL, Barry CE III: Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008;76:2333-2340.
-
(2008)
Infect Immun
, vol.76
, pp. 2333-2340
-
-
Via, L.E.1
Lin, P.L.2
Ray, S.M.3
Carrillo, J.4
Allen, S.S.5
Eum, S.Y.6
Taylor, K.7
Klein, E.8
Manjunatha, U.9
Gonzales, J.10
Lee, E.G.11
Park, S.K.12
Raleigh, J.A.13
Cho, S.N.14
McMurray, D.N.15
Flynn, J.L.16
Barry, C.E.17
-
31
-
-
55849117720
-
Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis
-
Hoff DR, Caraway ML, Brooks EJ, Driver ER, Ryan GJ, Peloquin CA, Orme IM, Basaraba RJ, Lenaerts AJ: Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis. Antimicrob Agents Chemother 2008;52:4137-4140.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 4137-4140
-
-
Hoff, D.R.1
Caraway, M.L.2
Brooks, E.J.3
Driver, E.R.4
Ryan, G.J.5
Peloquin, C.A.6
Orme, I.M.7
Basaraba, R.J.8
Lenaerts, A.J.9
-
32
-
-
60549117313
-
Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis
-
Nedeltchev GG, Raghunand TR, Jassal MS, Lun S, Cheng QJ, Bishai WR: Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis. Infect Immun 2009;77:598-603.
-
(2009)
Infect Immun
, vol.77
, pp. 598-603
-
-
Nedeltchev, G.G.1
Raghunand, T.R.2
Jassal, M.S.3
Lun, S.4
Cheng, Q.J.5
Bishai, W.R.6
-
33
-
-
17144386211
-
Ipr1 gene mediates innate immunity to tuberculosis
-
Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, Higgins DE, Daly MJ, Bloom BR, Kramnik I: Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005;434:767-772.
-
(2005)
Nature
, vol.434
, pp. 767-772
-
-
Pan, H.1
Yan, B.S.2
Rojas, M.3
Shebzukhov, Y.V.4
Zhou, H.5
Kobzik, L.6
Higgins, D.E.7
Daly, M.J.8
Bloom, B.R.9
Kramnik, I.10
|